查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1931189

毛细管定序市场按产品类型、工作流程、技术和应用划分－全球预测，2026-2032年

Capillary Sequencing Market by Product Type, Workflow, Technology, Application - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2025 年毛细管定序市场价值为 1.3958 亿美元，预计到 2026 年将成长至 1.537 亿美元，年复合成长率为 6.34%，到 2032 年将达到 2.1474 亿美元。

关键市场统计数据
基准年 2025 1.3958亿美元
预计年份：2026年 1.537亿美元
预测年份 2032 2.1474亿美元
复合年增长率 (%) 6.34%

全面说明毛细管定序的持续重要性、其技术基础及其在现代基因组分析工作流程中的地位

毛细管定序是一项基础性的DNA分析技术，即使在平行定序平台不断发展的今天，它在应用科学和诊断领域仍保持着重要的地位。其在标靶定序中展现出的精准性、长读长序列相对于短扩增子的清晰度以及完善的监管记录，使其成为许多实验室工作流程中不可或缺的组成部分。本文将毛细管定序置于更广泛的基因组学生态系统中，阐述其保持竞争优势的领域以及它如何与新兴的高通量定序方法相辅相成。

对技术、软体和应用方面的重大变革进行了深入分析，这些变革正在重新定义毛细管定序的采用和长期效用。

毛细管定序领域正经历多重变革，这些变革正在重新定义其价值提案和应用模式。检测方法的进步，特别是雷射诱导萤光和灵敏的电化学方法，提高了信噪比并降低了单次样本的失败率。同时，毛细管布置的模组化和坚固耐用的电泳基质使得实验室能够根据自身的通量需求定制仪器，从而提高了不同终端用户之间的成本效益。

分析不断变化的美国关税政策和贸易趋势对毛细管定序相关人员的采购、供应链韧性和业务连续性的影响

近期关税政策和贸易摩擦为毛细管定序系统及其耗材的采购和供应链管理带来了更复杂的挑战。进口设备和组件的关税推高了到岸成本，促使机构买家重新评估采购计划，并优先选择库存充足的本地分销合作伙伴。供应商则透过多元化製造地、策略性地储备聚合物基质和检测器等关键组件，以及重新谈判合约以透过价格和保固条款来分散关税风险等方式应对挑战。

基于全面细分的洞察分析，涵盖毛细管定序中的产品类型、应用需求、最终使用者要求、工作流程依赖关係和技术选择。

从细緻的细分观点可以揭示毛细管定序系中需求、投资和创新之间的交集。产品类型、仪器、试剂盒和试剂以及软体和服务各自发挥不同的作用。仪器涵盖多种配置，包括24毛细管系统、48毛细管系统、96毛细管系统以及少于24根毛细管的系统，使实验室能够在通量和资本投入之间取得平衡。试剂盒和试剂包括毛细管阵列耗材、DNA聚合酵素试剂盒和染料终止剂试剂盒，这些对于保持运行一致性和数据可靠性至关重要。软体和服务包括数据分析软体以及维护和支援服务。在数据分析软体中，碱基识别软体、序列比对软体和变异分析软体对于将原始数据转化为可操作的结果至关重要。同时，维护和支援服务，包括校准和检验、技术支援和培训服务，确保了营运的连续性和合规性。

策略区域分析重点在于影响全球主要市场毛细管定序技术应用的法规结构、供应链和实验室基础设施。

区域趋势正在影响毛细管定序技术的采购重点、监管互动和竞争格局。在美洲，成熟的实验室基础设施和完善的法医学及临床网路推动了对检验的平台和可靠的售后服务的需求。同时，创新中心和诊断市场也促使供应商提供响应迅速的技术支持，并与临床资讯系统整合。欧洲、中东和非洲（EMEA）地区的监管环境各不相同，一些市场受到严格的监管，而另一些市场则经历了诊断技术的快速普及，这凸显了对可适应性强的检验方案、多语言培训材料和灵活的分销模式的需求。亚太地区的应用模式也呈现出多样性，多个国家的研究和临床能力迅速扩展，同时又注重成本效益高的工作流程和本地技术伙伴关係，这迫使供应商对其商业模式和区域服务进行客製化。

从分析和企业层面的观点，概述如何建立整合的产品系列、服务模式和策略伙伴关係，从而在毛细管定序领域建立竞争优势。

毛细管定序系统中的关键参与者透过整合可靠的仪器、检验的耗材和先进的数据分析软体来脱颖而出。能够透过优化试剂稳定性降低总体拥有成本、透过预防性维护延长仪器运作以及提供无缝软体更新（在不中断检验工作流程的情况下改进碱基识别和变异分析）的机构，将获得竞争优势。仪器供应商和软体开发人员之间的合作，透过简化数据管道和减轻人工解读的负担，可以加快获得洞见的速度；而与学术实验室和法医实验室的合作，则可以提高检测性能和应用率。

为供应商、实验室和服务供应商提供实际有效的建议，以提高毛细管定序产品的相关性、增强供应链韧性并提高客户维繫

产业领导者应优先投资于能够提升端到端工作流程可靠性并加快结果获取速度的环节，尤其是在样品製备、电泳和数据分析的交叉领域。企业可以透过将检验的试剂组与仪器捆绑销售，并提供认证培训和校准计划，从而提供差异化价值，最大限度地降低临床和法医学用户的采用门槛。在采购和供应链规划方面，建立多个生产和分销地点可以降低关税带来的干扰，并缩短关键耗材的补货週期。

一种透明且稳健的调查方法，描述了多源数据、专家咨询和分析框架的整合，用于深入了解毛细管定序。

本研究整合了定性和定量信息，旨在全面、可重复地展现毛细管定序的现状。研究方法结合了与来自学术界、临床界、工业界和法医学领域的实验室主任、技术负责人和采购专业人员的面对面访谈，以了解操作流程、检验要求和采购驱动因素。二级资讯来源包括同行评审的技术文献、已发布的监管指南、製造商文件和行业新闻，追踪技术趋势、产品发布和不断发展的应用领域。透过对这些资讯进行三角验证，确保我们的结论既有实务经验支撑，又有文献记载的技术性能佐证。

一份权威的综合分析报告，重点阐述了技术、服务和供应链措施的策略协调，以确保毛细管定序技术的永续应用和影响。

总之，毛细管定序在准确性、读取清晰度和法规遵循方面仍然占据着重要的市场地位。了解该技术持久相关人员并投资于整合检验的耗材、可靠的仪器和先进数据分析解决方案的利益相关者，将释放其持久的营运和科研价值。硬体配置、检测方法和电泳基质之间的相互作用会影响技术性能和总营运成本，因此，根据实验室需求选择合适的采购方案至关重要。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 毛细管定序市场（依产品类型划分）

  • 装置
  • 试剂盒和试剂
    • 毛细管阵列耗材
    • DNA聚合酵素试剂盒
    • 染料终止剂套装
  • 软体和服务
    • 数据分析软体
      • 基准确定软体
      • 序列比对软体
      • 变异分析软体
    • 维护和支援服务
      • 校对和检验
      • 技术支援
      • 培训服务

9. 依工作流程分類的毛细管定序市场

  • 数据分析
    • 基准测定
    • 序列组装
    • 变异调用
  • 样品製备
    • DNA萃取与纯化
    • 样品製备
  • 定序
    • 毛细管电泳
    • 染料终止剂化学

第十章 毛细管定序市场（依技术划分）

  • 微血管数量
    • 24条毛细血管
    • 4条毛细血管
    • 48根微血管
    • 8根微血管
    • 96根微血管
  • 检测方法
    • 电化学检测
    • 雷射诱导萤光
  • 电泳技术
    • 基于聚合物的电泳
    • 筛分基质电泳

第十一章 毛细管定序市场（依应用领域划分）

  • 农业和畜牧业调查
    • 动物遗传学
    • 植物基因体学
  • 诊断
    • 癌症基因体学
    • 临床诊断
    • 基因疾病检测
  • 法医学/亲子鑑定
    • 刑事法医学
    • 亲子鑑定
  • 研究与开发
    • 表观遗传学研究
    • 基因组研究
    • 转录组学调查

第十二章 毛细管定序市场（依地区划分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 毛细管定序市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 各国毛细管定序市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章：美国毛细管定序市场

第十六章：中国的毛细管定序市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Agilent Technologies, Inc.
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • BGI Genomics Co., Ltd.
  • Bio-Rad Laboratories, Inc.
  • Eurofins Genomics LLC
  • GE Healthcare Life Sciences
  • GENEWIZ, Inc.
  • Hitachi, Ltd.
  • Illumina, Inc.
  • Macrogen, Inc.
  • Merck KGaA
  • Oxford Nanopore Technologies plc
  • Pacific Biosciences of California, Inc.
  • PerkinElmer, Inc.
  • Promega Corporation
  • Roche Holding AG
  • Shimadzu Corporation
  • Sigma-Aldrich Co. LLC
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
  • Waters Corporation
Product Code: MRR-7B550E008DA9

The Capillary Sequencing Market was valued at USD 139.58 million in 2025 and is projected to grow to USD 153.70 million in 2026, with a CAGR of 6.34%, reaching USD 214.74 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 139.58 million
Estimated Year [2026] USD 153.70 million
Forecast Year [2032] USD 214.74 million
CAGR (%) 6.34%

A comprehensive introduction explaining the enduring relevance of capillary sequencing, its technical foundations, and how it fits into modern genomics workflows

Capillary sequencing remains a foundational DNA analysis technology with enduring relevance across applied sciences and diagnostics, even as parallel sequencing platforms advance. Its proven accuracy for targeted sequencing, long-read clarity for small amplicons, and established regulatory pedigree make it an essential component of many laboratory workflows. This introduction situates capillary sequencing within the broader genomics ecosystem, describing where it retains comparative advantages and how it complements newer high-throughput approaches.

Laboratories rely on capillary systems for applications that prioritize single-read accuracy, forensic STR analysis, and routine clinical confirmatory testing, and the technology continues to evolve through incremental enhancements in detection sensitivity, automation, and integrated data analysis. Instrumentation, consumables, and software ecosystems have matured to support streamlined sample-to-answer processes, while aftermarket services such as calibration and technical support underpin long-term operational reliability. Transition points, such as the migration from manual to automated sample preparation and the integration of advanced base calling algorithms, are central to how organizations derive efficiency gains.

In this section, readers will find an accessible overview of technical principles, pragmatic use cases, and stakeholder expectations that shape procurement and deployment decisions. The emphasis is on actionable context: how capillary sequencing fits into contemporary laboratory strategy, the operational levers managers use to preserve accuracy and throughput, and the critical interfaces-sample prep, electrophoresis, detection, and data analysis-where innovation delivers measurable benefits.

Insightful analysis of the critical technological, software, and application-driven shifts redefining capillary sequencing adoption and long-term utility

The capillary sequencing landscape is experiencing several transformative shifts that are redefining value propositions and adoption patterns. Advances in detection methods, particularly improvements in laser-induced fluorescence and more sensitive electrochemical approaches, have enhanced signal-to-noise ratios and lowered per-sample failure rates. Concurrently, modularity in capillary count configurations and ruggedized electrophoresis matrices has allowed laboratories to calibrate instruments to throughput needs, improving cost alignment across diverse end users.

Software-centric transformations are equally consequential. Enhanced base calling algorithms, sequence alignment capabilities, and variant analysis pipelines are moving from standalone tools to integrated platforms that reduce manual curation and accelerate interpretation. This software evolution is tightly coupled with expanded maintenance and support offerings, as manufacturers and third-party providers deliver calibration, validation, and training services to ensure analytical reproducibility and regulatory compliance.

Market dynamics are also influenced by evolving application demand. Forensics and paternity testing continue to depend on the proven accuracy of capillary systems, while diagnostic and research sectors increasingly combine capillary workflows with orthogonal sequencing technologies to achieve confirmatory and long-read objectives. These shifts underscore a broader pattern: incremental innovation across hardware, consumables, and software is driving renewed relevance, even as the genomics ecosystem diversifies. Understanding these dynamics is essential for stakeholders aiming to optimize investments and anticipate where strategic differentiation will emerge.

Analysis of how evolving United States tariff policies and trade dynamics are affecting procurement, supply chain resilience, and operational continuity for capillary sequencing stakeholders

Recent tariff policies and trade friction have introduced layers of complexity to the procurement and supply chain management of capillary sequencing systems and consumables. Tariffs on imported instrumentation and component parts can increase landed costs, prompting institutional buyers to reassess purchasing timelines and to prioritize local distribution partners with inventory buffers. Suppliers have responded through diversified manufacturing footprints, strategic stockpiling of critical components such as polymer matrices and detectors, and contract renegotiations that reallocate tariff exposures through pricing or warranty terms.

Beyond direct cost implications, tariffs can also affect product roadmaps and aftermarket support. When sourcing becomes uncertain, manufacturers may delay planned rollouts or concentrate product support in regions with more predictable trade conditions. For laboratories, this can translate into longer procurement cycles, cautious adoption of newer instrument models, and greater emphasis on maintenance contracts to extend the life of existing assets. In addition, the reshaping of global logistics networks affects lead times for kits and reagents, increasing the importance of robust inventory management and forward-looking supplier relationships.

Overall, trade policy shifts serve as a reminder that operational resilience is not solely a function of in-house capacity but also of strategic supplier management, distribution agreements, and contingency planning. Organizations that proactively reassess sourcing strategies, fortify supply contracts, and cultivate alternative logistics pathways are better positioned to mitigate tariff-driven disruptions and to sustain critical sequencing operations without compromising data quality or regulatory obligations.

Comprehensive segmentation-driven insights mapping product typologies, application demands, end-user requirements, workflow dependencies, and technology choices for capillary sequencing

A nuanced segmentation lens reveals where demand, investment, and innovation converge across the capillary sequencing ecosystem. Looking at product type, instruments, kits and reagents, and software and services each play distinct roles. Instruments span a range of configurations including 24 capillary systems, 48 capillary systems, 96 capillary systems, and less than 24 capillary systems, allowing laboratories to balance throughput and capital intensity. Kits and reagents encompass capillary array consumables, DNA polymerase kits, and dye terminator kits that are integral to maintaining run consistency and data fidelity. Software and services include data analysis software and maintenance and support services; within data analysis software, base calling software, sequence alignment software, and variant analysis software are essential for converting raw traces into actionable results, while maintenance and support services cover calibration and validation, technical support, and training services that ensure operational continuity and regulatory readiness.

Application segmentation highlights differentiated technical demands and regulatory pressures. Agriculture and animal research includes animal genetics and plant genomics projects that prioritize robustness and cost-effectiveness. Diagnostics encompasses cancer genomics, clinical diagnostics, and genetic disease testing, where analytical sensitivity, validated workflows, and traceable quality controls are paramount. Forensics and paternity testing break down into criminal forensics and paternity testing use cases that demand chain-of-custody integrity and reproducible electropherogram interpretation. Research and development is driven by epigenetics research, genomics research, and transcriptomics research, each demanding flexible sample preparation and tailored data analysis capabilities.

End-user segmentation further clarifies procurement behavior and service expectations. Academic and research institutes, including government research institutes and universities, often prioritize flexibility and training, while clinical and diagnostic laboratories, comprising hospital-based labs and independent diagnostic labs, emphasize validated assays and turnaround time. Contract research organizations vary by scale, from large CROs to small and medium CROs, and have differing throughput commitments, contract structures, and service level needs. Pharmaceutical and biotechnology companies, including large pharma and small and medium biotech, pursue integrated solutions that align with regulatory programs and drug development timelines.

Workflow segmentation maps the operational stages where investments generate the greatest marginal value. Data analysis covers base calling, sequence assembly, and variant calling workflows that can materially reduce manual oversight when automated and validated. Sample preparation covers DNA extraction and purification and library preparation steps that are foundational to downstream performance. Sequencing workflows themselves include capillary electrophoresis and dye terminator chemistry, where reagent quality and electrophoresis matrices directly influence read quality and run stability.

Technology segmentation exposes the engineering choices that influence performance and cost. Capillary count options such as 24 capillaries, 4 capillaries, 48 capillaries, 8 capillaries, and 96 capillaries provide laboratories with throughput scaling options. Detection methods, including electrochemical detection and laser-induced fluorescence, determine sensitivity and instrument complexity, while electrophoresis technology choices such as polymer-based electrophoresis and sieving matrix electrophoresis affect resolution and run reproducibility. Together, these segmentation dimensions present a granular blueprint for investment and innovation priorities that align with specific use cases, regulatory constraints, and operational scale.

Strategic regional analysis revealing how regulatory frameworks, supply chains, and laboratory infrastructure influence capillary sequencing adoption across major global markets

Regional dynamics shape procurement priorities, regulatory interactions, and the competitive landscape for capillary sequencing technologies. In the Americas, a mature laboratory infrastructure and established forensic and clinical networks drive demand for validated platforms and robust aftermarket services, while innovation hubs and diagnostic markets push suppliers to provide rapid technical support and integration with clinical informatics. Europe, Middle East & Africa presents a heterogeneous regulatory landscape with high regulatory scrutiny in some markets and emerging diagnostic adoption in others, which emphasizes the need for adaptable validation packages, multilingual training materials, and flexible distribution models. Asia-Pacific exhibits diversified adoption patterns, where rapid expansion of research and clinical capacities in several countries coexists with an emphasis on cost-effective workflows and local technical partnerships, prompting vendors to customize commercial models and regional service footprints.

Across these regions, logistical considerations such as shipping times for reagents, regional availability of calibration services, and local regulatory approvals influence purchasing cadences and supplier selection. Transitioning from regional observations to strategic implications, laboratories and suppliers operating in the Americas tend to prioritize comprehensive service bundles and integration with electronic medical records, stakeholders in Europe, Middle East & Africa often seek modular solutions paired with rigorous compliance documentation, and Asia-Pacific partners require scalable product offerings with localized training and supply chain resilience. This regional mosaic underscores that a one-size-fits-all commercial strategy is unlikely to succeed; rather, successful market approaches are built on responsive service models and region-specific value propositions.

Analytical company-level perspectives that outline how integrated product portfolios, service models, and strategic partnerships establish competitive advantage in capillary sequencing

Leading players in the capillary sequencing ecosystem differentiate through integrated offerings that pair reliable instrumentation with validated consumables and sophisticated data analysis software. Competitive advantage accrues to organizations that excel at reducing total cost of ownership by optimizing reagent stability, extending instrument uptime through proactive maintenance, and providing seamless software updates that improve base calling and variant analysis without disrupting validated workflows. Partnerships between instrument vendors and software developers accelerate time-to-insight by streamlining data pipelines and reducing manual interpretation overhead, while collaborations with academic centers and forensic laboratories help refine assay performance and promote broader adoption.

Commercial strategies reflect a balance between direct sales, distributor networks, and service-centric business models. Companies that effectively bundle training, calibration, and technical support build stronger long-term customer relationships and enhance retention rates. Innovation also manifests in aftermarket services, where remote diagnostics, predictive maintenance, and tailored service-level agreements increase operational predictability for laboratory managers. Finally, firms investing in regulatory support services and documentation reduce friction for clinical and forensic customers, enabling faster validation and deployment. These company-level tactics illustrate how product excellence combined with service depth and strategic partnerships creates durable market positioning.

Practical and high-impact recommendations for vendors, laboratories, and service providers to enhance product relevance, supply chain resilience, and customer retention in capillary sequencing

Industry leaders should prioritize investments that improve end-to-end workflow reliability and reduce time-to-answer, focusing on the junctions where sample preparation, electrophoresis, and data analysis intersect. Firms can deliver differentiated value by bundling validated reagent kits with instruments and by offering certified training and calibration programs, thereby minimizing adoption friction for clinical and forensic users. In procurement and supply chain planning, cultivating multiple manufacturing and distribution touchpoints reduces exposure to tariff-driven disruption and shortens replenishment cycles for critical consumables.

On the technology front, companies should emphasize software modularity and interoperability, ensuring that base calling, sequence alignment, and variant analysis tools integrate with laboratory information management systems and clinical informatics platforms. Service strategies that include remote diagnostics, predictive maintenance, and flexible support tiers will address diverse customer needs and improve lifetime customer value. For market expansion, aligning commercial strategies with regional regulatory requirements and developing localized training content will accelerate adoption in heterogeneous markets. Finally, proactive collaboration with end users for co-validation studies and method transfer initiatives will both strengthen product credibility and accelerate customer onboarding, creating a virtuous cycle of innovation and adoption.

Transparent and robust research methodology explaining the multi-source data synthesis, expert consultations, and analytical frameworks used to derive insights about capillary sequencing

This research synthesizes qualitative and quantitative inputs to build a comprehensive, reproducible perspective on the capillary sequencing landscape. The approach combines primary engagements with laboratory directors, technical managers, and procurement specialists across academic, clinical, industrial, and forensic settings to capture operational realities, validation requirements, and purchase drivers. Secondary sources include peer-reviewed technical literature, open regulatory guidance, manufacturer documentation, and industry press to track technological trends, product launches, and evolving application areas. Triangulation across these inputs ensures that conclusions are grounded in both practical experience and documented technical performance.

Analytical techniques involve segmentation mapping to align product features with end-user needs, workflow analysis to identify bottlenecks and improvement levers, and scenario-based supply chain assessment to evaluate resilience against trade and logistics disruptions. Expert validation rounds were used to refine technical assessments for instrument configurations, detection modalities, and electrophoresis materials. Limitations and scope boundaries were explicitly defined to ensure clarity on what the analysis covers; where gaps exist, the methodology highlights areas requiring ongoing primary research. Together, these methods produce robust, context-aware insights that support operational decisions and strategic planning for stakeholders across the capillary sequencing ecosystem.

A conclusive synthesis stressing the strategic alignment of technology, service, and supply chain initiatives to ensure sustainable capillary sequencing adoption and impact

In closing, capillary sequencing continues to occupy an important niche where accuracy, read clarity, and regulatory familiarity are decisive. Stakeholders who appreciate the technology's enduring strengths and who invest in integrated solutions that combine validated consumables, dependable instrumentation, and advanced data analysis will extract sustained operational and scientific value. The interplay between hardware configurations, detection methods, and electrophoresis matrices shapes both technical performance and total cost of operation, so purposeful alignment of procurement choices with laboratory requirements is essential.

Operational resilience, enabled through diversified supply chains, strong aftermarket services, and proactive calibration programs, mitigates external shocks such as trade disruptions. Software investments that reduce manual interpretation burden and that integrate with broader laboratory systems convert technical capability into practical throughput improvements. Ultimately, the path to sustainable adoption lies in coupling technical excellence with service depth and in tailoring offerings to regional regulatory realities and end-user workflows, thereby ensuring that capillary sequencing continues to serve as a reliable pillar in genomics research, diagnostics, and applied sciences.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Capillary Sequencing Market, by Product Type

  • 8.1. Instruments
  • 8.2. Kits & Reagents
    • 8.2.1. Capillary Array Consumables
    • 8.2.2. DNA Polymerase Kits
    • 8.2.3. Dye Terminator Kits
  • 8.3. Software & Services
    • 8.3.1. Data Analysis Software
      • 8.3.1.1. Base Calling Software
      • 8.3.1.2. Sequence Alignment Software
      • 8.3.1.3. Variant Analysis Software
    • 8.3.2. Maintenance & Support Services
      • 8.3.2.1. Calibration & Validation
      • 8.3.2.2. Technical Support
      • 8.3.2.3. Training Services

9. Capillary Sequencing Market, by Workflow

  • 9.1. Data Analysis
    • 9.1.1. Base Calling
    • 9.1.2. Sequence Assembly
    • 9.1.3. Variant Calling
  • 9.2. Sample Preparation
    • 9.2.1. DNA Extraction & Purification
    • 9.2.2. Library Preparation
  • 9.3. Sequencing
    • 9.3.1. Capillary Electrophoresis
    • 9.3.2. Dye Terminator Chemistry

10. Capillary Sequencing Market, by Technology

  • 10.1. Capillary Count
    • 10.1.1. 24 Capillaries
    • 10.1.2. 4 Capillaries
    • 10.1.3. 48 Capillaries
    • 10.1.4. 8 Capillaries
    • 10.1.5. 96 Capillaries
  • 10.2. Detection Method
    • 10.2.1. Electrochemical Detection
    • 10.2.2. Laser-Induced Fluorescence
  • 10.3. Electrophoresis Technology
    • 10.3.1. Polymer-Based Electrophoresis
    • 10.3.2. Sieving Matrix Electrophoresis

11. Capillary Sequencing Market, by Application

  • 11.1. Agriculture & Animal Research
    • 11.1.1. Animal Genetics
    • 11.1.2. Plant Genomics
  • 11.2. Diagnostics
    • 11.2.1. Cancer Genomics
    • 11.2.2. Clinical Diagnostics
    • 11.2.3. Genetic Disease Testing
  • 11.3. Forensics & Paternity Testing
    • 11.3.1. Criminal Forensics
    • 11.3.2. Paternity Testing
  • 11.4. Research & Development
    • 11.4.1. Epigenetics Research
    • 11.4.2. Genomics Research
    • 11.4.3. Transcriptomics Research

12. Capillary Sequencing Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Capillary Sequencing Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Capillary Sequencing Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Capillary Sequencing Market

16. China Capillary Sequencing Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Agilent Technologies, Inc.
  • 17.6. Beckman Coulter, Inc.
  • 17.7. Becton, Dickinson and Company
  • 17.8. BGI Genomics Co., Ltd.
  • 17.9. Bio-Rad Laboratories, Inc.
  • 17.10. Eurofins Genomics LLC
  • 17.11. GE Healthcare Life Sciences
  • 17.12. GENEWIZ, Inc.
  • 17.13. Hitachi, Ltd.
  • 17.14. Illumina, Inc.
  • 17.15. Macrogen, Inc.
  • 17.16. Merck KGaA
  • 17.17. Oxford Nanopore Technologies plc
  • 17.18. Pacific Biosciences of California, Inc.
  • 17.19. PerkinElmer, Inc.
  • 17.20. Promega Corporation
  • 17.21. Roche Holding AG
  • 17.22. Shimadzu Corporation
  • 17.23. Sigma-Aldrich Co. LLC
  • 17.24. Takara Bio Inc.
  • 17.25. Thermo Fisher Scientific Inc.
  • 17.26. Waters Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CAPILLARY SEQUENCING MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL CAPILLARY SEQUENCING MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY WORKFLOW, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES CAPILLARY SEQUENCING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA CAPILLARY SEQUENCING MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY KITS & REAGENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY KITS & REAGENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY KITS & REAGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY KITS & REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY CAPILLARY ARRAY CONSUMABLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY CAPILLARY ARRAY CONSUMABLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY CAPILLARY ARRAY CONSUMABLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY DNA POLYMERASE KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY DNA POLYMERASE KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY DNA POLYMERASE KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY DYE TERMINATOR KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY DYE TERMINATOR KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY DYE TERMINATOR KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY DATA ANALYSIS SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY BASE CALLING SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY BASE CALLING SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY BASE CALLING SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY SEQUENCE ALIGNMENT SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY SEQUENCE ALIGNMENT SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY SEQUENCE ALIGNMENT SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY VARIANT ANALYSIS SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY VARIANT ANALYSIS SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY VARIANT ANALYSIS SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY MAINTENANCE & SUPPORT SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY MAINTENANCE & SUPPORT SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY MAINTENANCE & SUPPORT SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY MAINTENANCE & SUPPORT SERVICES, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY CALIBRATION & VALIDATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY CALIBRATION & VALIDATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY CALIBRATION & VALIDATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY TECHNICAL SUPPORT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY TECHNICAL SUPPORT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY TECHNICAL SUPPORT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY TRAINING SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY TRAINING SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY TRAINING SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY DATA ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY DATA ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY DATA ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY DATA ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY BASE CALLING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY BASE CALLING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY BASE CALLING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY SEQUENCE ASSEMBLY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY SEQUENCE ASSEMBLY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY SEQUENCE ASSEMBLY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY VARIANT CALLING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY VARIANT CALLING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY VARIANT CALLING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY SAMPLE PREPARATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY SAMPLE PREPARATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY SAMPLE PREPARATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY SAMPLE PREPARATION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY DNA EXTRACTION & PURIFICATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY DNA EXTRACTION & PURIFICATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY DNA EXTRACTION & PURIFICATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY LIBRARY PREPARATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY LIBRARY PREPARATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY LIBRARY PREPARATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY CAPILLARY ELECTROPHORESIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY CAPILLARY ELECTROPHORESIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY CAPILLARY ELECTROPHORESIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY DYE TERMINATOR CHEMISTRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY DYE TERMINATOR CHEMISTRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY DYE TERMINATOR CHEMISTRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY CAPILLARY COUNT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY CAPILLARY COUNT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY CAPILLARY COUNT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY CAPILLARY COUNT, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY 24 CAPILLARIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY 24 CAPILLARIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY 24 CAPILLARIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY 4 CAPILLARIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY 4 CAPILLARIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY 4 CAPILLARIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY 48 CAPILLARIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY 48 CAPILLARIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY 48 CAPILLARIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY 8 CAPILLARIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY 8 CAPILLARIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY 8 CAPILLARIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY 96 CAPILLARIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY 96 CAPILLARIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY 96 CAPILLARIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY DETECTION METHOD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY DETECTION METHOD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY DETECTION METHOD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY DETECTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY ELECTROCHEMICAL DETECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY ELECTROCHEMICAL DETECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY ELECTROCHEMICAL DETECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY LASER-INDUCED FLUORESCENCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY LASER-INDUCED FLUORESCENCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY LASER-INDUCED FLUORESCENCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY ELECTROPHORESIS TECHNOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY ELECTROPHORESIS TECHNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY ELECTROPHORESIS TECHNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY ELECTROPHORESIS TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY POLYMER-BASED ELECTROPHORESIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY POLYMER-BASED ELECTROPHORESIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY POLYMER-BASED ELECTROPHORESIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY SIEVING MATRIX ELECTROPHORESIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY SIEVING MATRIX ELECTROPHORESIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY SIEVING MATRIX ELECTROPHORESIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY AGRICULTURE & ANIMAL RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY AGRICULTURE & ANIMAL RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY AGRICULTURE & ANIMAL RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY AGRICULTURE & ANIMAL RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY ANIMAL GENETICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY ANIMAL GENETICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY ANIMAL GENETICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY PLANT GENOMICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY PLANT GENOMICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY PLANT GENOMICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY CANCER GENOMICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY CANCER GENOMICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY CANCER GENOMICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY GENETIC DISEASE TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY GENETIC DISEASE TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY GENETIC DISEASE TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY FORENSICS & PATERNITY TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY FORENSICS & PATERNITY TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY FORENSICS & PATERNITY TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY FORENSICS & PATERNITY TESTING, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY CRIMINAL FORENSICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY CRIMINAL FORENSICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY CRIMINAL FORENSICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY PATERNITY TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY PATERNITY TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY PATERNITY TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 158. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 159. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 160. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY EPIGENETICS RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 162. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY EPIGENETICS RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 163. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY EPIGENETICS RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 164. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY GENOMICS RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 165. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY GENOMICS RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 166. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY GENOMICS RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 167. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY TRANSCRIPTOMICS RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 168. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY TRANSCRIPTOMICS RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 169. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY TRANSCRIPTOMICS RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 170. GLOBAL CAPILLARY SEQUENCING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 171. AMERICAS CAPILLARY SEQUENCING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 172. AMERICAS CAPILLARY SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. AMERICAS CAPILLARY SEQUENCING MARKET SIZE, BY KITS & REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 174. AMERICAS CAPILLARY SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 175. AMERICAS CAPILLARY SEQUENCING MARKET SIZE, BY DATA ANALYSIS SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 176. AMERICAS CAPILLARY SEQUENCING MARKET SIZE, BY MAINTENANCE & SUPPORT SERVICES, 2018-2032 (USD MILLION)
  • TABLE 177. AMERICAS CAPILLARY SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 178. AMERICAS CAPILLARY SEQUENCING MARKET SIZE, BY DATA ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 179. AMERICAS CAPILLARY SEQUENCING MARKET SIZE, BY SAMPLE PREPARATION, 2018-2032 (USD MILLION)
  • TABLE 180. AMERICAS CAPILLARY SEQUENCING MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 181. AMERICAS CAPILLARY SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 182. AMERICAS CAPILLARY SEQUENCING MARKET SIZE, BY CAPILLARY COUNT, 2018-2032 (USD MILLION)
  • TABLE 183. AMERICAS CAPILLARY SEQUENCING MARKET SIZE, BY DETECTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 184. AMERICAS CAPILLARY SEQUENCING MARKET SIZE, BY ELECTROPHORESIS TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 185. AMERICAS CAPILLARY SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 186. AMERICAS CAPILLARY SEQUENCING MARKET SIZE, BY AGRICULTURE & ANIMAL RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 187. AMERICAS CAPILLARY SEQUENCING MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 188. AMERICAS CAPILLARY SEQUENCING MARKET SIZE, BY FORENSICS & PATERNITY TESTING, 2018-2032 (USD MILLION)
  • TABLE 189. AMERICAS CAPILLARY SEQUENCING MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 190. NORTH AMERICA CAPILLARY SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 191. NORTH AMERICA CAPILLARY SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 192. NORTH AMERICA CAPILLARY SEQUENCING MARKET SIZE, BY KITS & REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 193. NORTH AMERICA CAPILLARY SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 194. NORTH AMERICA CAPILLARY SEQUENCING MARKET SIZE, BY DATA ANALYSIS SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 195. NORTH AMERICA CAPILLARY SEQUENCING MARKET SIZE, BY MAINTENANCE & SUPPORT SERVICES, 2018-2032 (USD MILLION)
  • TABLE 196. NORTH AMERICA CAPILLARY SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 197. NORTH AMERICA CAPILLARY SEQUENCING MARKET SIZE, BY DATA ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 198. NORTH AMERICA CAPILLARY SEQUENCING MARKET SIZE, BY SAMPLE PREPARATION, 2018-2032 (USD MILLION)
  • TABLE 199. NORTH AMERICA CAPILLARY SEQUENCING MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 200. NORTH AMERICA CAPILLARY SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 201. NORTH AMERICA CAPILLARY SEQUENCING MARKET SIZE, BY CAPILLARY COUNT, 2018-2032 (USD MILLION)
  • TABLE 202. NORTH AMERICA CAPILLARY SEQUENCING MARKET SIZE, BY DETECTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 203. NORTH AMERICA CAPILLARY SEQUENCING MARKET SIZE, BY ELECTROPHORESIS TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 204. NORTH AMERICA CAPILLARY SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 205. NORTH AMERICA CAPILLARY SEQUENCING MARKET SIZE, BY AGRICULTURE & ANIMAL RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 206. NORTH AMERICA CAPILLARY SEQUENCING MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 207. NORTH AMERICA CAPILLARY SEQUENCING MARKET SIZE, BY FORENSICS & PATERNITY TESTING, 2018-2032 (USD MILLION)
  • TABLE 208. NORTH AMERICA CAPILLARY SEQUENCING MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 209. LATIN AMERICA CAPILLARY SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 210. LATIN AMERICA CAPILLARY SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 211. LATIN AMERICA CAPILLARY SEQUENCING MARKET SIZE, BY KITS & REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 212. LATIN AMERICA CAPILLARY SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 213. LATIN AMERICA CAPILLARY SEQUENCING MARKET SIZE, BY DATA ANALYSIS SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 214. LATIN AMERICA CAPILLARY SEQUENCING MARKET SIZE, BY MAINTENANCE & SUPPORT SERVICES, 2018-2032 (USD MILLION)
  • TABLE 215. LATIN AMERICA CAPILLARY SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 216. LATIN AMERICA CAPILLARY SEQUENCING MARKET SIZE, BY DATA ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 217. LATIN AMERICA CAPILLARY SEQUENCING MARKET SIZE, BY SAMPLE PREPARATION, 2018-2032 (USD MILLION)
  • TABLE 218. LATIN AMERICA CAPILLARY SEQUENCING MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 219. LATIN AMERICA CAPILLARY SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 220. LATIN AMERICA CAPILLARY SEQUENCING MARKET SIZE, BY CAPILLARY COUNT, 2018-2032 (USD MILLION)
  • TABLE 221. LATIN AMERICA CAPILLARY SEQUENCING MARKET SIZE, BY DETECTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 222. LATIN AMERICA CAPILLARY SEQUENCING MARKET SIZE, BY ELECTROPHORESIS TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 223. LATIN AMERICA CAPILLARY SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 224. LATIN AMERICA CAPILLARY SEQUENCING MARKET SIZE, BY AGRICULTURE & ANIMAL RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 225. LATIN AMERICA CAPILLARY SEQUENCING MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 226. LATIN AMERICA CAPILLARY SEQUENCING MARKET SIZE, BY FORENSICS & PATERNITY TESTING, 2018-2032 (USD MILLION)
  • TABLE 227. LATIN AMERICA CAPILLARY SEQUENCING MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 228. EUROPE, MIDDLE EAST & AFRICA CAPILLARY SEQUENCING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 229. EUROPE, MIDDLE EAST & AFRICA CAPILLARY SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 230. EUROPE, MIDDLE EAST & AFRICA CAPILLARY SEQUENCING MARKET SIZE, BY KITS & REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 231. EUROPE, MIDDLE EAST & AFRICA CAPILLARY SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 232. EUROPE, MIDDLE EAST & AFRICA CAPILLARY SEQUENCING MARKET SIZE, BY DATA ANALYSIS SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 233. EUROPE, MIDDLE EAST & AFRICA CAPILLARY SEQUENCING MARKET SIZE, BY MAINTENANCE & SUPPORT SERVICES, 2018-2032 (USD MILLION)
  • TABLE 234. EUROPE, MIDDLE EAST & AFRICA CAPILLARY SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 235. EUROPE, MIDDLE EAST & AFRICA CAPILLARY SEQUENCING MARKET SIZE, BY DATA ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 236. EUROPE, MIDDLE EAST & AFRICA CAPILLARY SEQUENCING MARKET SIZE, BY SAMPLE PREPARATION, 2018-2032 (USD MILLION)
  • TABLE 237. EUROPE, MIDDLE EAST & AFRICA CAPILLARY SEQUENCING MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 238. EUROPE, MIDDLE EAST & AFRICA CAPILLARY SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 239. EUROPE, MIDDLE EAST & AFRICA CAPILLARY SEQUENCING MARKET SIZE, BY CAPILLARY COUNT, 2018-2032 (USD MILLION)
  • TABLE 240. EUROPE, MIDDLE EAST & AFRICA CAPILLARY SEQUENCING MARKET SIZE, BY DETECTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 241. EUROPE, MIDDLE EAST & AFRICA CAPILLARY SEQUENCING MARKET SIZE, BY ELECTROPHORESIS TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 242. EUROPE, MIDDLE EAST & AFRICA CAPILLARY SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 243. EUROPE, MIDDLE EAST & AFRICA CAPILLARY SEQUENCING MARKET SIZE, BY AGRICULTURE & ANIMAL RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 244. EUROPE, MIDDLE EAST & AFRICA CAPILLARY SEQUENCING MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 245. EUROPE, MIDDLE EAST & AFRICA CAPILLARY SEQUENCING MARKET SIZE, BY FORENSICS & PATERNITY TESTING, 2018-2032 (USD MILLION)
  • TABLE 246. EUROPE, MIDDLE EAST & AFRICA CAPILLARY SEQUENCING MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 247. EUROPE CAPILLARY SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 248. EUROPE CAPILLARY SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 249. EUROPE CAPILLARY SEQUENCING MARKET SIZE, BY KITS & REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 250. EUROPE CAPILLARY SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 251. EUROPE CAPILLARY SEQUENCING MARKET SIZE, BY DATA ANALYSIS SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 252. EUROPE CAPILLARY SEQUENCING MARKET SIZE, BY MAINTENANCE & SUPPORT SERVICES, 2018-2032 (USD MILLION)
  • TABLE 253. EUROPE CAPILLARY SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 254. EUROPE CAPILLARY SEQUENCING MARKET SIZE, BY DATA ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 255. EUROPE CAPILLARY SEQUENCING MARKET SIZE, BY SAMPLE PREPARATION, 2018-2032 (USD MILLION)
  • TABLE 256. EUROPE CAPILLARY SEQUENCING MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 257. EUROPE CAPILLARY SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 258. EUROPE CAPILLARY SEQUENCING MARKET SIZE, BY CAPILLARY COUNT, 2018-2032 (USD MILLION)
  • TABLE 259. EUROPE CAPILLARY SEQUENCING MARKET SIZE, BY DETECTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 260. EUROPE CAPILLARY SEQUENCING MARKET SIZE, BY ELECTROPHORESIS TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 261. EUROPE CAPILLARY SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 262. EUROPE CAPILLARY SEQUENCING MARKET SIZE, BY AGRICULTURE & ANIMAL RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 263. EUROPE CAPILLARY SEQUENCING MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 264. EUROPE CAPILLARY SEQUENCING MARKET SIZE, BY FORENSICS & PATERNITY TESTING, 2018-2032 (USD MILLION)
  • TABLE 265. EUROPE CAPILLARY SEQUENCING MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 266. MIDDLE EAST CAPILLARY SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 267. MIDDLE EAST CAPILLARY SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 268. MIDDLE EAST CAPILLARY SEQUENCING MARKET SIZE, BY KITS & REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 269. MIDDLE EAST CAPILLARY SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 270. MIDDLE EAST CAPILLARY SEQUENCING MARKET SIZE, BY DATA ANALYSIS SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 271. MIDDLE EAST CAPILLARY SEQUENCING MARKET SIZE, BY MAINTENANCE & SUPPORT SERVICES, 2018-2032 (USD MILLION)
  • TABLE 272. MIDDLE EAST CAPILLARY SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 273. MIDDLE EAST CAPILLARY SEQUENCING MARKET SIZE, BY DATA ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 274. MIDDLE EAST CAPILLARY SEQUENCING MARKET SIZE, BY SAMPLE PREPARATION, 2018-2032 (USD MILLION)
  • TABLE 275. MIDDLE EAST CAPILLARY SEQUENCING MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 276. MIDDLE EAST CAPILLARY SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 277. MIDDLE EAST CAPILLARY SEQUENCING MARKET SIZE, BY CAPILLARY COUNT, 2018-2032 (USD MILLION)
  • TABLE 278. MIDDLE EAST CAPILLARY SEQUENCING MARKET SIZE, BY DETECTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 279. MIDDLE EAST CAPILLARY SEQUENCING MARKET SIZE, BY ELECTROPHORESIS TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 280. MIDDLE EAST CAPILLARY SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 281. MIDDLE EAST CAPILLARY SEQUENCING MARKET SIZE, BY AGRICULTURE & ANIMAL RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 282. MIDDLE EAST CAPILLARY SEQUENCING MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 283. MIDDLE EAST CAPILLARY SEQUENCING MARKET SIZE, BY FORENSICS & PATERNITY TESTING, 2018-2032 (USD MILLION)
  • TABLE 284. MIDDLE EAST CAPILLARY SEQUENCING MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 285. AFRICA CAPILLARY SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 286. AFRICA CAPILLARY SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 287. AFRICA CAPILLARY SEQUENCING MARKET SIZE, BY KITS & REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 288. AFRICA CAPILLARY SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 289. AFRICA CAPILLARY SEQUENCING MARKET SIZE, BY DATA ANALYSIS SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 290. AFRICA CAPILLARY SEQUENCING MARKET SIZE, BY MAINTENANCE & SUPPORT SERVICES, 2018-2032 (USD MILLION)
  • TABLE 291. AFRICA CAPILLARY SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 292. AFRICA CAPILLARY SEQUENCING MARKET SIZE, BY DATA ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 293. AFRICA CAPILLARY SEQUENCING MARKET SIZE, BY SAMPLE PREPARATION, 2018-2032 (USD MILLION)
  • TABLE 294. AFRICA CAPILLARY SEQUENCING MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 295. AFRICA CAPILLARY SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 296. AFRICA CAPILLARY SEQUENCING MARKET SIZE, BY CAPILLARY COUNT, 2018-2032 (USD MILLION)
  • TABLE 297. AFRICA CAPILLARY SEQUENCING MARKET SIZE, BY DETECTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 298. AFRICA CAPILLARY SEQUENCING MARKET SIZE, BY ELECTROPHORESIS TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 299. AFRICA CAPILLARY SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 300. AFRICA CAPILLARY SEQUENCING MARKET SIZE, BY AGRICULTURE & ANIMAL RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 301. AFRICA CAPILLARY SEQUENCING MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 302. AFRICA CAPILLARY SEQUENCING MARKET SIZE, BY FORENSICS & PATERNITY TESTING, 2018-2032 (USD MILLION)
  • TABLE 303. AFRICA CAPILLARY SEQUENCING MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 304. ASIA-PACIFIC CAPILLARY SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 305. ASIA-PACIFIC CAPILLARY SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 306. ASIA-PACIFIC CAPILLARY SEQUENCING MARKET SIZE, BY KITS & REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 307. ASIA-PACIFIC CAPILLARY